![icad mammography icad mammography](https://www.icadmed.com/blogimageuploads/adobestock_108405713.jpg)
Likewise, with the addition of our recently introduced ProFound AI Risk offering, we believe we will move mammography from what is today an age-based screening paradigm to a risk-adjusted precision screening paradigm that is personalized for every woman.” “ProFound AI powered by Panorama offers unparalleled benefits to patients and radiologists alike, including a clinically proven improvement in sensitivity and specificity, which dramatically improves reading accuracy for mammograms and reduces the rate of false positives. “Our partnership with Solis underscores our ongoing commitment to improving women’s health and we are thrilled that even more women across the United States will benefit from our revolutionary technology that is helping to improve lives,” said Michael Klein, Chairman and CEO of iCAD.
![icad mammography icad mammography](https://healthcare-in-europe.com/media/product/2492/image-01-icad-profound-ai.jpg)
The ProFound AI platform powered by Panorama is compatible with all leading mammography systems and allows for seamless integration with major PACS for decision support capabilities across large networks. It assists radiologists by rapidly and accurately analyzing each individual DBT image to identify potentially malignant lesions. ProFound AI for DBT is a high-performing workflow solution trained with the latest in deep-learning AI capabilities. “ProFound AI will further enhance patient care and outcomes for the over one million women we serve while also supporting our continued growth and expansion.”
![icad mammography icad mammography](https://www.karaoke5.com/images/programma.jpg)
“After a thorough evaluation of all available AI solutions, we have chosen iCAD’s ProFound AI platform as our sole breast health AI solution to integrate with our Hologic 3D mammography systems throughout our entire network,” said Grant Davies, President and Chief Executive Officer of Solis Mammography. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, and Solis Mammography, the largest independent provider of mammography and breast health services in the United States, today announced a five-year partnership whereby iCAD will provide Solis Mammography’s nationwide network with its latest artificial intelligence (AI) breast health solutions, including ProFound AI® for DBT and ProFound AI Risk, the first and only clinical decision support tool to provide an accurate two-year breast cancer risk estimation based on a screening mammogram. NASHUA, NH and DALLAS, TX – Decem– iCAD, Inc. *ProFound AI for DBT is proven to curtail workflow challenges substantially by reducing radiologists’ reading time by 52.7%, thereby reducing by half the amount of time it takes radiologists to read 3D mammography datasets.Īgreement Positions Both Companies for Growth Leading-edge AI Technology to be Installed Across Largest Independent Provider of Mammography and Breast Health Services’ Network
![icad mammography icad mammography](https://manualmachine.com/html/99/9984/99845b7f849c0bc6261ec89c9cc67249e5ab461d43e6aff904e41b37534f6714/img-1-PyjjjvojKI.png)
long term risk of developing breast cancer based solely on a screening mammogram. *ProFound AI Risk is the only commercially available risk assessment solution to provide a short term vs. This leads to earlier breast cancer detection and reduced rate of false positive *Delivers clinically proven improvements in sensitivity, specificity, time-savings and recall rates. The technology rapidly and accurately analyzes each DBT image, or slice, and provides radiologists with key information, such as Certainty of Finding lesion and Case Scores, which assists in clinical decision-making and improving reading efficiency.
#ICAD MAMMOGRAPHY SOFTWARE#
ProFound AI, which aids in the detection of breast cancer in 3D mammography, or digital breast tomosynthesis (DBT), became the first software of its kind to be FDA-cleared in December 2018. The agreement underscores promise of shifting mammography from age-based screening paradigm to a risk-adjusted precision screening paradigm personalized for every woman. ICAD ProFound AI for 3D Mammography and ProFound AI Risk will be deployed to 100 percent of Solis Mammography’s installed base, a majority of which are Hologic systems.